Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Solar-powered hospitals possible
Health

Solar-powered hospitals possible

Sunlight may be more than disinfectant.

Ian Llewellyn 16 Oct 2025
Southern Cross pays record 3.8 million claims
Law & Regulation

Southern Cross pays record 3.8 million claims

Rising demand and more frequent claims push up costs, directly impacting premiums.

John Anthony 30 Sep 2025
Fisher & Paykel Healthcare shares dip on new tariff fears
Markets

Fisher & Paykel Healthcare shares dip on new tariff fears

US Department of Commerce launched a “Section 232” on medical products.

Gregor Thompson 25 Sep 2025
NZer creates world's first waste-free drink
Retail

NZer creates world's first waste-free drink

They are tiny, concentrated balls of flavours and vitamins which dissolve in liquid.